Density‐associated loss of functional receptors for somatomedin‐C/insulinlike growth factor I (SM‐C/IGF‐I) on cultured human fibroblast monolayers
- 1 November 1984
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 121 (2), 419-424
- https://doi.org/10.1002/jcp.1041210221
Abstract
The mitogenic activity of somatomedin-C/insulinlike growth factor-I (SM-C/IGF-I) appears to be greatly influenced by cell culture conditions, especially the presence of other growth factors and nutrients in the culture medium. To investigate the effect of cell density on SM-C/IGF-I activity, we have evaluated SM-C/IGF-I binding and stimulation of DNA synthesis and cell replication as a function of cell density in cultured human fibroblast monolayers. At fibroblast concentrations of 2.7 × 105 and 1.48 × 106 cells per 60-mm dish, specific binding of [125I]SM-C/IGF-I per 106 cells was 170% higher in sparse than dense monolayers (9.3% vs. 3.4%). Increased binding in sparse monolayers was attributable to approximately twice as many receptors in sparse as in dense cells (31,000 vs. 16,000 sites per cell), as well as to a modest increase in the affinity constant. Similarly, half-maximal stimulation of [methyl-3H]thymidine incorporation was achieved at SM-C/IGF-I concentrations of 2.5 ng/ml in sparse cells but required 20 ng/ml in dense cells. Although this required only 45% occupancy of membrane receptors on sparse cells, and almost 80% occupancy on dense cells, the total number of occupied receptors was similar in both sparse and dense cells (approximately 13,000 receptors/cell for half-maximal stimulation). The presence of increased numbers of “functional receptors” on sparse fibroblasts thus results in enhanced sensitivity to SM-C/IGF-I stimulation of DNA synthesis and cell replication. Progressive decreases in the number of functional receptors, secondary to cell crowding, may contribute to density-dependent inhibition of fibroblast growth.This publication has 23 references indexed in Scilit:
- Insulin‐like growth factor I/somatomedin‐C (IGF‐I/SM‐C) and glucocorticoids synergistically regulate mitosis in competent human fibroblastsJournal of Cellular Physiology, 1983
- Insulin Binding and Degradation in Vascular Endothelial Cells: Modulation by Cell Growth and Culture Organization*Endocrinology, 1983
- A Radioimmunoassay for Insulin-like Growth Factor II Specific for the C-Peptide Region*Journal of Clinical Endocrinology & Metabolism, 1982
- Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle.Proceedings of the National Academy of Sciences, 1980
- Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*Journal of Clinical Endocrinology & Metabolism, 1980
- Density-dependent regulation of growth of BSC-1 cells in cell culture: control of growth by serum factors.Proceedings of the National Academy of Sciences, 1977
- Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by RadioimmunoassayJournal of Clinical Investigation, 1977
- Control of growth of mammalian cells in cell cultureNature, 1975
- Somatomedin: Proposed Designation for Sulphation FactorNature, 1972
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962